The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that Portuguese Authority for Medicines and Health Product (INFARMED) on 1st April 2018 in Lisbon ordered the withdrawal of Mentanor, Flupirtine capsule 100 milligram because its active ingredient (Flupirtine) is harmful to the liver.
A safety review conducted by the European Medicine Agency (EMA) revealed that the risks of using Metanor, Flupirtine capsule 100 milligram outweigh the benefits.
- Importers, Distributors and retailers and consumers in possession of Mentanor Flupirtine capsule 100mg should immediately stop their distribution and sale.
- Healthcare providers and consumers are implored to submit the product in their possession to the nearest NAFDAC office for appropriate action.
- Adverse dug events following the use of these products should be reported to NAFDAC via PRASCOR (20543 TOLL FREE from all networks) or via pharmacovigilance @gov.ng
NAFDAC……………Safeguarding the Health of the Nation!!!
Signed: Management
Was this helpful?
Thanks for your feedback!
